title: Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
abstract: Recent studies have shown that trans-phosphorylation of the Abl SH3 domain at Tyr89 by Src-family kinases is required for the full transforming activity of Bcr-Abl. Tyr89 localizes to a binding surface of the SH3 domain that engages the SH2-kinase linker in the crystal structure of the c-Abl core. Displacement of SH3 from the linker is likely to influence efficient downregulation of c-Abl. Hydrogen-deuterium exchange (HX) and mass spectrometry (MS) were used to investigate whether Tyr89 phosphorylation affects the ability of the SH3 domain to interact intramolecularly with the SH2-kinase linker in cis as well as other peptide ligands in trans. HX MS analysis of SH3 binding showed that when various Abl constructs were phosphorylated at Tyr89 by the Src-family kinase Hck, SH3 was unable to engage a high-affinity ligand in trans and that interaction with the linker in cis was reduced dramatically in a construct containing the SH3 and SH2 domains plus the linker. Phosphorylation of the Abl SH3 domain on Tyr89 also interfered with binding to the negative regulatory protein Abi-1 in trans. Site-directed mutagenesis of Tyr89 and Tyr245, another tyrosine phosphorylation site located in the linker that may also influence SH3 binding, implicated Tyr89 as the key residue necessary for disrupting regulation after phosphorylation. These results imply that phosphorylation at Tyr89 by Src-family kinases prevents engagement of the Abl SH3 domain with its intramolecular binding partner leading to enhanced Abl kinase activity and cellular signaling.
authors.affiliation: Chemistry & Chemical Biology and The Barnett Institute of Chemical & Biological Analysis, Northeastern University, Boston, MA 02115, USA.
authors.forename: Shugui
authors.initials: S
authors.lastname: Chen
authors.forename: Linda P
authors.initials: LP
authors.lastname: O'Reilly
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Smithgall
authors.forename: John R
authors.initials: JR
authors.lastname: Engen
mesh_terms: D000595:Amino Acid Sequence; D001665:Binding Sites; D016044:Fusion Proteins, bcr-abl / Q000737:chemistry / Q000378:metabolism; D016313:Genes, abl; D006801:Humans; D013058:Mass Spectrometry; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010766:Phosphorylation; D011487:Protein Conformation; D016315:Proto-Oncogene Proteins c-abl / Q000737:chemistry* / Q000378:metabolism*; D015398:Signal Transduction; D014443:Tyrosine / Q000235:genetics / Q000378:metabolism*; D018909:src Homology Domains / Q000235:genetics
chemical_list: D014443:Tyrosine; D016044:Fusion Proteins, bcr-abl; D016315:Proto-Oncogene Proteins c-abl
references.citation: J Biol Chem. 2006 Oct 13;281(41):30907-16
references.pmid: 16912036
references.citation: J Biol Chem. 2000 Nov 10;275(45):35631-7
references.pmid: 10964922
references.citation: Nat Genet. 1998 Mar;18(3):280-2
references.pmid: 9500553
references.citation: Mass Spectrom Rev. 2006 Jan-Feb;25(1):158-70
references.pmid: 16208684
references.citation: Oncogene. 2001 Nov 22;20(53):7744-52
references.pmid: 11753652
references.citation: J Biol Chem. 1997 Dec 26;272(52):33260-70
references.pmid: 9407116
references.citation: Mol Cell Proteomics. 2006 Jan;5(1):172-81
references.pmid: 16204703
references.citation: Mol Cell. 2003 Jul;12(1):27-37
references.pmid: 12887890
references.citation: Nat Rev Drug Discov. 2007 Oct;6(10):834-48
references.pmid: 17853901
references.citation: J Am Soc Mass Spectrom. 2006 Dec;17(12):1700-3
references.pmid: 16931036
references.citation: Protein Sci. 1993 Apr;2(4):522-31
references.pmid: 8390883
references.citation: Protein Sci. 2007 Apr;16(4):572-81
references.pmid: 17327393
references.citation: Mol Cell Biol. 2003 Jun;23(11):3884-96
references.pmid: 12748290
references.citation: Cell. 2003 Mar 21;112(6):831-43
references.pmid: 12654249
references.citation: Cell. 2002 Jan 25;108(2):247-59
references.pmid: 11832214
references.citation: Biochemistry. 2008 May 27;47(21):5795-803
references.pmid: 18452309
references.citation: Genes Dev. 1995 Nov 1;9(21):2583-97
references.pmid: 7590237
references.citation: Nature. 1982 Dec 23;300(5894):765-7
references.pmid: 6960256
references.citation: Cell. 2003 Mar 21;112(6):845-57
references.pmid: 12654250
references.citation: EMBO J. 1994 Dec 1;13(23):5598-604
references.pmid: 7988556
references.citation: Nature. 1983 Nov 17-23;306(5940):239-42
references.pmid: 6316147
references.citation: Cell. 2003 Mar 21;112(6):859-71
references.pmid: 12654251
references.citation: Mol Cell Biol. 1994 May;14(5):2883-94
references.pmid: 8164650
references.citation: Genes Dev. 1995 Nov 1;9(21):2569-82
references.pmid: 7590236
references.citation: J Mol Biol. 2006 Apr 14;357(5):1592-604
references.pmid: 16487539
references.citation: Mol Cell. 2006 Mar 17;21(6):787-98
references.pmid: 16543148
references.citation: Nat Rev Mol Cell Biol. 2004 Jan;5(1):33-44
references.pmid: 14708008
references.citation: Biochim Biophys Acta. 2008 May;1783(5):737-47
references.pmid: 18328268
references.citation: Protein Sci. 2006 Jan;15(1):65-73
references.pmid: 16322569
references.citation: J Am Soc Mass Spectrom. 2006 Nov;17(11):1498-1509
references.pmid: 16875839